Mutations in gene CEL VNTR is cause of diabetes syndrome and exogenous pancreatic dysfunction

2006, Number 1

Rev Endocrinol Nutr 2006; 14 (1)

Rodríguez-Carranza SI

Language: Spanish
References: 6
Page: 36-38
PDF size: 89.12 Kb.

Text Extraction

No abstract

REFERENCES

Cavalot F, Bonomo K, Perna P, Bacillo E, Salacone P et al. Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlations with both residual β-cell secretion and metabolic control in type 1 diabetic subjects. Diabetes Care 2004; 27(8): 2052-2054.
Clark A, de Koning EJ, Hattersley AT, Hansen BC, Yajnik CS, Poulton J. Pancreatic pathology in non-insulin dependent diabetes. Diabetes Res Clin Pract 1995; 28 Suppl: S39-47.
Yilmaztepe A, Ulukaya E, Ersoy C, Yilmaz M, Tokullugil HA. Investigation of fecal pancreatic elastase-1 levels in type 2 diabetic patients. Turk J Gastroenterol 2005; 16(2): 75-80.
Sziegoleit A, Linder D. Studies on sterol-binding capacity of human pancreatic elastase. Gastroenterology 1991; 100: 768-774.
Hardt PD, Hauenschild A, Nalop J, Marzeion AM, Jaeger C et al. High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients. Pancreatology 2003; 3(5): 395-402.
Hardt PD, Hauenschild A, Jaeger C, Teichmann J, Bretzel R, Kloer HU et al. High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. A prospective multicenter study. Dig Dis Sci 2003; 48(9): 1688-1692.